BenjaminEJ, ViraniSS, CallawayCW, et al.Heart disease and stroke statistics—2018 update: A report from the American Heart Association. Circulation, 2018; 137:e67–e492.
2.
McSweeneyJC, RosenfeldAG, AbelWM, et al.Preventing and experiencing ischemic heart disease as a woman: State of the science: A scientific statement from the American Heart Association. Circulation, 2016; 133:1302–1331.
3.
MurphyNF, SimpsonCR, MacIntyreK, McAlisterFA, ChalmersJ, McMurrayJJV. Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: Age, sex and socioeconomic disparities: A population-based study. Heart, 2006; 92:1047–1054.
4.
FihnSD, GardinJM, AbramsJ, et al.2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the. Circulation, 2012; 126:e354–e471.
5.
WengerNK, ChaitmanB, VetrovecGW. Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials. Am J Cardiol, 2007; 99:11–18.
6.
MehtaP, SharmaS, MinissianM, et al.Ranolazine reduces angina in women with ischemic heart disease: Results of an open label, multi-center trial. J Womens Health, 2018 [Epub ahead of print]; DOI: 10.1089/jwh.2018.7201.
7.
SpertusJA, WinderJA, DewhurstTA, et al.Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. J Am Coll Cardiol, 1995; 25:333–341.
8.
SaraJD, WidmerRJ, MatsuzawaY, LennonRJ, LermanLO, LermanA. Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease. JACC Cardiovasc Interv, 2015; 8:1445–1453.
9.
FordTJ, StanleyB, GoodR, et al.Stratified medical therapy using invasive coronary function testing in angina: CorMicA Trial. J Am Coll Cardiol, 2018; 72(23 Pt A):2841–2855.
10.
TurgeonRD, PearsonGJ, GrahamMM. Pharmacologic treatment of patients with myocardial ischemia with no obstructive coronary artery disease. Am J Cardiol, 2018; 121:888–895.
